Publication | Closed Access

Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women

Estrogen ReplacementBone HealthCombined Low DoseGynecologyMenopauseIsoflavone Derivative IpriflavonePostreproductive HealthEndocrinologyMedicineOsteoporosisOrthopaedic SurgeryWomen's HealthMenopause Hormone Therapy